Literature DB >> 12234477

A fluorescence-based high performance liquid chromatographic method for the characterization of palmitoyl acyl transferase activity.

Amanda S Varner1, Mackenzie L De Vos, Steffen P Creaser, Blake R Peterson, Charles D Smith.   

Abstract

Although protein palmitoylation is essential for targeting many important signaling proteins to the plasma membrane, the mechanism by which palmitoylation occurs is uncharacterized, since the enzyme(s) responsible for this modification remain unidentified. To study palmitoyl acyl transferase (PAT) activity, we developed an in vitro palmitoylation (IVP) assay using a fluorescently labeled substrate peptide, mimicking the N-terminal palmitoylation motif of proteins such as non-receptor Src-related tyrosine kinases. The palmitoylated and non-palmitoylated forms of the peptide were resolved by reverse-phase HPLC and detected by fluorescence. The method was optimized for PAT activity using lysates from the MCF-7 and Hep-G2 human tumor cell lines. The PAT activity was inhibited by boiling, reducing the incubation temperature, or adding 10 microM 2-bromopalmitate, a known palmitoylation inhibitor. This IVP assay provides the first method that is suitable to study all facets of the palmitoylation reaction, including peptide palmitoylation by PAT(s), depalmitoylation by thioesterases, and evaluation of potential palmitoylation inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234477     DOI: 10.1016/s0003-2697(02)00212-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

1.  DHHC20: a human palmitoyl acyltransferase that causes cellular transformation.

Authors:  Jeremiah M Draper; Charles D Smith
Journal:  Mol Membr Biol       Date:  2010-04       Impact factor: 2.857

Review 2.  In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptides.

Authors:  Charles E Ducker; Jeremiah M Draper; Zuping Xia; Charles D Smith
Journal:  Methods       Date:  2006-10       Impact factor: 3.608

3.  Cellular palmitoylation and trafficking of lipidated peptides.

Authors:  Jeremiah M Draper; Zuping Xia; Charles D Smith
Journal:  J Lipid Res       Date:  2007-05-24       Impact factor: 5.922

4.  Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity.

Authors:  Edward B Thorp; Joseph A Boscarino; Hillary L Logan; Jeffrey T Goletz; Thomas M Gallagher
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 5.  Acylation in trypanosomatids: an essential process and potential drug target.

Authors:  Amanda M Goldston; Aabha I Sharma; Kimberly S Paul; David M Engman
Journal:  Trends Parasitol       Date:  2014-06-19

6.  Discovery and characterization of inhibitors of human palmitoyl acyltransferases.

Authors:  Charles E Ducker; Lindsay K Griffel; Ryan A Smith; Staci N Keller; Yan Zhuang; Zuping Xia; John D Diller; Charles D Smith
Journal:  Mol Cancer Ther       Date:  2006-07       Impact factor: 6.261

7.  Characterization of human palmitoyl-acyl transferase activity using peptides that mimic distinct palmitoylation motifs.

Authors:  Amanda S Varner; Charles E Ducker; Zuping Xia; Yan Zhuang; Mackenzie L De Vos; Charles D Smith
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

8.  DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities.

Authors:  Benjamin C Jennings; Maurine E Linder
Journal:  J Biol Chem       Date:  2012-01-13       Impact factor: 5.157

9.  Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase.

Authors:  Charles E Ducker; Erin M Stettler; Kevin J French; John J Upson; Charles D Smith
Journal:  Oncogene       Date:  2004-12-09       Impact factor: 9.867

10.  Use of micellar electrokinetic chromatography to measure palmitoylation of a peptide.

Authors:  Laura M Borland; Nancy L Allbritton
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-30       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.